The probiotic Lactobacillus plantarum counteracts TNF-α-induced downregulation of SMCT1 expression and function

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 299, Issue 4, 2010, Pages

  Borthakur, Alip ^a   Anbazhagan, Arivarasu N ^a   Kumar, Anoop ^a   Raheja, Geetu ^a   Singh, Varsha ^a   Ramaswamy, Krishnamurthy ^a   Dudeja, Pradeep K ^a  

^a NONE

Author keywords

Inflammatory bowel disease; Intestinal epithelial cell 6; Short chain fatty acid; SLC5A8

Indexed keywords

MESSENGER RNA; PROBIOTIC AGENT; SODIUM COUPLED MONOCARBOXYLATE TRANSPORTER 1; SODIUM ION; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BUTYRIC ACID DERIVATIVE; CATION TRANSPORT PROTEIN; MONOCARBOXYLATE TRANSPORTER; SLC5A8 PROTEIN, HUMAN; SLC5A8 PROTEIN, MOUSE; SODIUM; SODIUM-COUPLED MONOCARBOXYLATE TRANSPORTER 1, RAT;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STRAIN CACO 2; COLON; DOWN REGULATION; DRUG EFFICACY; GENE EXPRESSION; HUMAN; ILEAL CONDUIT; IN VIVO CULTURE; INTESTINE EPITHELIUM CELL; LACTOBACILLUS PLANTARUM; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SODIUM TRANSPORT; ANIMAL; CELL LINE; CELL MEMBRANE; GENETICS; INTESTINE; METABOLISM; PHYSIOLOGY;

ANIMALS; BUTYRATES; CATION TRANSPORT PROTEINS; CELL LINE; CELL MEMBRANE; DOWN-REGULATION; HUMANS; INTESTINES; LACTOBACILLUS PLANTARUM; MICE; MONOCARBOXYLIC ACID TRANSPORTERS; PROBIOTICS; RATS; RNA, MESSENGER; SODIUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77957333510     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00279.2010     Document Type: Article

References (44)

1. Alrefai WA, Tyagi S, Gill R, Saksena S, Hadjiagapiou C, Mansour F, Ramaswamy K, Dudeja PK. Regulation of butyrate uptake in Caco-2 cells by phorbol 12-myristate 13-acetate. Am J Physiol Gastrointest Liver Physiol 286: G197-G203, 2004.
2. Balamurugan K, Said HM. Role of reduced folate carrier in intestinal folate uptake. Am J Physiol Cell Physiol 291: C189-C193, 2006.
3. Barrett KE. Building better bugs to deliver biologics in intestinal inflammation. Gut 59: 427-428, 2010.
4. Bhattacharya S, Ray RM, Johnson LR. Prevention of TNF-alphainduced apoptosis in polyamine-depleted IEC-6 cells is mediated through the activation of ERK1/2. Am J Physiol Gastrointest Liver Physiol 286: G479-G490, 2004.
5. Binder HJ. Role of colonic short-chain fatty acid transport in diarrhea. Annu Rev Physiol 72: 297-313, 2010.
6. Boirivant M, Strober W. The mechanism of action of probiotics. Curr Opin Gastroenterol 23: 679-692, 2007.
7. Borthakur A, Gill RK, Hodges K, Ramaswamy K, Hecht G, Dudeja PK. Enteropathogenic Escherichia coli inhibits butyrate uptake in Caco-2 cells by altering the apical membrane MCT1 level. Am J Physiol Gastrointest Liver Physiol 290: G30-G35, 2006.
8. Borthakur A, Gill RK, Tyagi S, Koutsouris A, Alrefai WA, Hecht GA, Ramaswamy K, Dudeja PK. The probiotic Lactobacillus acidophilus stimulates chloride/hydroxyl exchange activity in human intestinal epithelial cells. J Nutr 138: 1355-1359, 2008.
9. Borthakur A, Saksena S, Gill RK, Alrefai WA, Ramaswamy K, Dudeja PK. Regulation of monocarboxylate transporter 1 (MCT1) promoter by butyrate in human intestinal epithelial cells: Involvement of NF-kappaB pathway. J Cell Biochem 103: 1452-1463, 2008.
10. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
11. Cui D, Morris ME. The drug of abuse gamma-hydroxybutyrate is a substrate for sodium-coupled monocarboxylate transporter (SMCT) 1 (SLC5A8): characterization of SMCT-mediated uptake and inhibition. Drug Metab Dispos 37: 1404-1410, 2009.
12. Dotan I, Rachmilewitz D. Probiotics in inflammatory bowel disease: possible mechanisms of action. Curr Opin Gastroenterol 21: 426-430, 2005.
13. Ganapathy V, Gopal E, Miyauchi S, Prasad PD. Biological functions of SLC5A8, a candidate tumour suppressor. Biochem Soc Trans 33: 237-240, 2005.
14. Ganapathy V, Thangaraju M, Gopal E, Martin PM, Itagaki S, Miyauchi S, Prasad PD. Sodium-coupled monocarboxylate transporters in normal tissues and in cancer. AAPS J 10: 193-199, 2008.
15. Gill RK, Saksena S, Alrefai WA, Sarwar Z, Goldstein JL, Carroll RE, Ramaswamy K, Dudeja PK. Expression and membrane localization of MCT isoforms along the length of the human intestine. Am J Physiol Cell Physiol 289: C846-C852, 2005.
16. Gupta N, Martin PM, Prasad PD, Ganapathy V. SLC5A8 (SMCT1)- mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter. Life Sci 78: 2419-2425, 2006.
17. Hadjiagapiou C, Borthakur A, Dahdal RY, Gill RK, Malakooti J, Ramaswamy K, Dudeja PK. Role of USF1 and USF2 as potential repressor proteins for human intestinal monocarboxylate transporter 1 promoter. Am J Physiol Gastrointest Liver Physiol 288: G1118-G1126, 2005.
18. Hadjiagapiou C, Schmidt L, Dudeja PK, Layden TJ, Ramaswamy K. Mechanism(s) of butyrate transport in Caco-2 cells: role of monocarboxylate transporter 1. Am J Physiol Gastrointest Liver Physiol 279: G775-G780, 2000.
19. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 27: 104-119, 2008.
20. Hijova E, Chmelarova A. Short chain fatty acids and colonic health. Bratisl Lek Listy 108: 354-358, 2007.
21. Isaacs K, Herfarth H. Role of probiotic therapy in IBD. Inflamm Bowel Dis 14: 1597-1605, 2008.
22. Kataria J, Li N, Wynn JL, Neu J. Probiotic microbes: do they need to be alive to be beneficial? Nutr Rev 67: 546-550, 2009.
23. Kolinska J, Lisa V, Clark JA, Kozakova H, Zakostelecka M, Khailova L, Sinkora M, Kitanovicova A, Dvorak B. Constitutive expression of IL-18 and IL-18R in differentiated IEC-6 cells: effect of TNF-alpha and IFN-gamma treatment. J Interferon Cytokine Res 28: 287-296, 2008.
24. Lambert DW, Wood IS, Ellis A, Shirazi-Beechey SP. Molecular changes in the expression of human colonic nutrient transporters during the transition from normality to malignancy. Br J Cancer 86: 1262-1269, 2002.
25. Ng SC, Hart AL, Kamm MA, Stagg AJ, Knight SC. Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis 15: 300-310, 2009.
26. Oelschlaeger TA. Mechanisms of probiotic actions: a review. Int J Med Microbiol 300: 57-62, 2010.
27. Ohland CL, Macnaughton WK. Probiotic bacteria and intestinal epithelial barrier function. Am J Physiol Gastrointest Liver Physiol 298: G807-G819, 2010.
28. Petrof EO, Claud EC, Sun J, Abramova T, Guo Y, Waypa TS, He SM, Nakagawa Y, Chang EB. Bacteria-free solution derived from Lactobacillus plantarum inhibits multiple NF-kappaB pathways and inhibits proteasome function. Inflamm Bowel Dis 15: 1537-1547, 2009.
29. Petrof EO, Kojima K, Ropeleski MJ, Musch MW, Tao Y, De Simone C, Chang EB. Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology 127: 1474-1487, 2004.
30. Raheja G, Singh V, Ma K, Boumendjel R, Borthakur A, Gill RK, Saksena S, Alrefai WA, Ramaswamy K, Dudeja PK. Lactobacillus acidophilus stimulates the expression of slc26a3 via a transcriptional mechanism. Am J Physiol Gastrointest Liver Physiol 298: G395-G401, 2010.
31. Rajgopal A, Sierra EE, Zhao R, Goldman ID. Expression of the reduced folate carrier SLC19A1 in IEC-6 cells results in two distinct transport activities. Am J Physiol Cell Physiol 281: C1579-C1586, 2001.
32. Resta-Lenert S, Barrett KE. Probiotics and commensals reverse TNF-alpha- and IFN-gamma-induced dysfunction in human intestinal epithelial cells. Gastroenterology 130: 731-746, 2006.
33. Resta-Lenert SC, Barrett KE. Modulation of intestinal barrier properties by probiotics: role in reversing colitis. Ann N Y Acad Sci 1165: 175-182, 2009.
34. Ritzhaupt A, Wood IS, Ellis A, Hosie KB, Shirazi-Beechey SP. Identification and characterization of a monocarboxylate transporter in pig and human colon: its potential to transport L-lactate as well as butyrate. J Physiol 513: 719-732, 1998.
35. Saksena S, Dwivedi A, Gill RK, Singla A, Alrefai WA, Malakooti J, Ramaswamy K, Dudeja PK. PKC-dependent stimulation of the human MCT1 promoter involves transcription factor AP2. Am J Physiol Gastrointest Liver Physiol 296: G275-G283, 2009.
36. Saksena S, Theegala S, Bansal N, Gill RK, Tyagi S, Alrefai WA, Ramaswamy K, Dudeja PK. Mechanisms underlying modulation of monocarboxylate transporter 1 (MCT1) by somatostatin in human intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 297: G878-G885, 2009.
37. Segain JP, Raingeard de la Bletiere D, Bourreille A, Leray V, Gervois N, Rosales C, Ferrier L, Bonnet C, Blottiere HM, Galmiche JP. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut 47: 397-403, 2000.
38. Tamboli CP, Neut C, Desreumaux P, Colombel JF. Dysbiosis in inflammatory bowel disease. Gut 53: 1-4, 2004.
39. Tao Y, Drabik KA, Waypa TS, Musch MW, Alverdy JC, Schneewind O, Chang EB, Petrof EO. Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am J Physiol Cell Physiol 290: C1018-C1030, 2006.
40. Thangaraju M, Cresci G, Itagaki S, Mellinger J, Browning DD, Berger FG, Prasad PD, Ganapathy V. Sodium-coupled transport of the short chain fatty acid butyrate by SLC5A8 and its relevance to colon cancer. J Gastrointest Surg 12: 1773-1781, 2008.
41. Thibault R, Blachier F, Darcy-Vrillon B, de Coppet P, Bourreille A, Segain JP. Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: A transport deficiency. Inflamm Bowel Dis 16: 684-695, 2010.
42. Thibault R, De Coppet P, Daly K, Bourreille A, Cuff M, Bonnet C, Mosnier JF, Galmiche JP, Shirazi-Beechey S, Segain JP. Downregulation of the monocarboxylate transporter 1 is involved in butyrate deficiency during intestinal inflammation. Gastroenterology 133: 1916-1927, 2007.
43. Treede I, Braun A, Jeliaskova P, Giese T, Fullekrug J, Griffiths G, Stremmel W, Ehehalt R. TNF-alpha-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells. BMC Gastroenterol 9: 53, 2009.
44. Vanderpool C, Yan F, Polk DB. Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis 14: 1585-1596, 2008.